SCHEMBL9998428

SCHEMBL9998428

CC(=O)OCC(=Cc1cccc(C(C)(C)C)c1)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP26B1 Q9NR63 2/20 0.41
CYP26A1 O43174 1/20 0.41
ALDH1A1 P00352 3/20 0.39
NR1H4 Q96RI1 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
BCHE P06276 2/20 0.36
LMNA P02545 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PAM P19021 1/20 0.35
ACHE P22303 1/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998423 1.00 CYP26B1 (0.41) CYP26B1CYP26A1ALDH1A1NR1H4CYP3A4
SCHEMBL9997754 0.86 LMNA (0.45) ALDH1A1NR1H4CYP3A4CYP2C9LMNA
SCHEMBL9997752 0.86 LMNA (0.45) ALDH1A1NR1H4CYP3A4CYP2C9LMNA
SCHEMBL9998278 0.85 ACHE (0.38) CYP26B1CYP26A1MEN1KMT2AACHE
SCHEMBL9998277 0.85 ACHE (0.38) CYP26B1CYP26A1MEN1KMT2AACHE
SCHEMBL9997387 0.85 ALDH1A1 (0.50) ALDH1A1NR1H4CYP3A4CYP2C9LMNA
SCHEMBL9997388 0.85 ALDH1A1 (0.50) ALDH1A1NR1H4CYP3A4CYP2C9LMNA
SCHEMBL9997493 0.84 ALDH1A1 (0.42) ALDH1A1NR1H4CYP3A4CYP2C9MEN1
SCHEMBL9997492 0.84 ALDH1A1 (0.42) ALDH1A1NR1H4CYP3A4CYP2C9MEN1
SCHEMBL9998527 0.84 ALDH1A1 (0.42) ALDH1A1CYP3A4CYP2C9LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP26B1 241/4885CYP26A1 265/4885ALDH1A1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.